ITEOS THERAPEUTICS INC (ITOS)
US46565G1040 - Common Stock
| 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | 2019 (2019-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| CASH FLOWS FROM OPERATING ACTIVITIES | ||||||||
| Net Income | -112.64M | 96.70M | 214.50M | -38.00M | -22.50M | |||
| Depreciation Amortization | 898.00K | 800.00K | 600.00K | 500.00K | 600.00K | |||
| Change In Working Capital | -8.80M | -228.50M | 284.20M | 9.30M | -1.10M | |||
| Interest Paid | N/A | N/A | N/A | 0.00 | 100.00K | |||
| Taxes Paid | 6.82M | 22.80M | 32.00M | 100.00K | 0.00 | |||
| Other non cash items | 16.79M | 19.80M | 13.80M | 3.00M | -200.00K | |||
| OPERATING CASH FLOW | -103.76M | -111.20M | 513.10M | -25.20M | -23.10M | |||
| CASH FLOWS FROM INVESTING ACTIVITIES | ||||||||
| Capital Expenditure | -3.06M | -1.10M | -1.20M | -400.00K | -700.00K | |||
| Other Investing Activity | 75.72M | -445.00M | N/A | N/A | -200.00K | |||
| INVESTING CASH FLOW | 72.66M | -446.10M | -1.20M | -400.00K | -900.00K | |||
| CASH FLOWS FROM FINANCING ACTIVITIES | ||||||||
| Stock Issued/Repurchased | 1.11M | 900.00K | 2.90M | 339.30M | 22.50M | |||
| Other Financing Activity | 0.00 | 1.10M | 700.00K | 1.00M | 100.00K | |||
| FINANCING CASH FLOW | 1.11M | 2.00M | 3.70M | 340.30M | 22.50M | |||
| Exchange Rate Effect | -3.60M | -8.50M | -3.20M | 1.70M | -500.00K | |||
| CHANGE IN CASH | -33.59M | -563.80M | 512.40M | 316.40M | -2.00M | |||
| FREE CASH FLOW | ||||||||
| Operating Cash Flow | -103.76M | -111.20M | 513.10M | -25.20M | -23.10M | |||
| Capital Expenditure | -3.06M | -1.10M | -1.20M | -400.00K | -700.00K | |||
| FREE CASH FLOW | -106.82M | -112.30M | 511.90M | -25.60M | -23.80M | |||
All data in USD